Clinical trials: Recurrent Stroke
Thrombosis
Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes"
The purpose of this study is to determine whether BMS-986141 is effective in reducing the recurrence of stroke in people who recently had a stroke, or a transient ischemic attack (known as a TIA or "mini stroke") and are…
- Trial name
- NCT02671461
- Testing
- BMS-986141, Aspirin
- Where
- 33 sites in United States, Japan
- Volunteers
- 16 people
- Sponsor
- Bristol-Myers Squibb
Stroke, Cardiovascular
Home-Based SolUtion for Remote Atrial Fibrillation Screening to PrevenT RecUrrence StrOke (HUA-TUO AF Trial)
Stroke remains the leading cause of mortality and morbidity worldwide. Patients surviving the first ever stroke remain at high risk of stroke recurrence.
- Trial name
- HUA-TUO (NCT04523649)
- Testing
- Remote atrial fibrillation screening with handheld single lead ECG recorder
- Volunteers
- 1,740 people
- Sponsor
- The University of Hong Kong
Stroke
High Intensity Interval Training After Stroke
The purpose of this study is to examine if high intensity interval training after stroke is more effective than standard care to increase maximal oxygen uptake, reduce known risk factors for recurrent stroke and improve function.
- Trial name
- NCT02550015
- Testing
- High intensity interval training, General information
- Where
- Norway
- Volunteers
- 70 people
- Sponsor
- Norwegian University of Science and Technology